Literature DB >> 17512111

Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.

Robert A Smith1, Rod A Lea, Stephen R Weinstein, Lyn R Griffiths.   

Abstract

Our laboratory has previously found that anti-mitogenic nuclear receptor mRNA is elevated in late stage tumours and this study was performed to scrutinize the possibility of cancer-stroma crosstalk using hormone signaling in these tissues. RNA levels in stromal tissue were examined for the estrogen alpha, estrogen beta, androgen, progesterone and glucocorticoid nuclear receptors by a semi-quantitative PCR. Significant differences in expression between the cancer stroma and control tissue were seen, analyzing for both cancer grade and estrogen receptor status. Stroma and control tissue were significantly different for the progesterone and glucocorticoid nuclear receptors (p=5.908 x 10(-7) and 2.761 x 10(-5), respectively). Glucocorticoid receptor also showed a significant increase to mRNA levels in the stroma of estrogen receptor negative tumours (p=5.85 x 10(-5)). By contrast, the estrogen receptors alpha and beta, those most closely associated with breast tissue growth, showed no significant change in mRNA (p=0.372 and 0.655, respectively). Androgen receptor mRNA also remained unaffected (p=0.174).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512111     DOI: 10.1016/j.canlet.2007.03.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level.

Authors:  Tina B Miranda; Ty C Voss; Myong-Hee Sung; Songjoon Baek; Sam John; Mary Hawkins; Lars Grøntved; R Louis Schiltz; Gordon L Hager
Journal:  Cancer Res       Date:  2013-06-26       Impact factor: 12.701

Review 2.  The influence of glucocorticoid signaling on tumor progression.

Authors:  Paul A Volden; Suzanne D Conzen
Journal:  Brain Behav Immun       Date:  2012-11-16       Impact factor: 7.217

3.  Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.

Authors:  Sarah A Andres; James L Wittliff
Journal:  Endocrine       Date:  2011-08-21       Impact factor: 3.633

Review 4.  Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.

Authors:  Henriett Butz; Attila Patócs
Journal:  Cancer Metastasis Rev       Date:  2022-06-27       Impact factor: 9.264

5.  Glucocorticoid resistance of migration and gene expression in a daughter MDA-MB-231 breast tumour cell line selected for high metastatic potential.

Authors:  Ebony R Fietz; Christine R Keenan; Guillermo López-Campos; Yan Tu; Cameron N Johnstone; Trudi Harris; Alastair G Stewart
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 6.  The glucocorticoid receptor signalling in breast cancer.

Authors:  Paraskevi Moutsatsou; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

7.  The Immunoexpression of Glucocorticoid Receptors in Breast Carcinomas, Lactational Change, and Normal Breast Epithelium and Its Possible Role in Mammary Carcinogenesis.

Authors:  Raja Alyusuf; Javed Fayyaz Wazir; Urmil Prabha Brahmi; Abdul Rahman Fakhro; Moiz Bakhiet
Journal:  Int J Breast Cancer       Date:  2017-11-19

Review 8.  A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?

Authors:  Emira Ayroldi; Lorenza Cannarile; Domenico V Delfino; Carlo Riccardi
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.